FabGennix International Revenue and Competitors
Estimated Revenue & Valuation
- FabGennix International's estimated annual revenue is currently $1.9M per year.
- FabGennix International's estimated revenue per employee is $155,000
Employee Data
- FabGennix International has 12 Employees.
- FabGennix International grew their employee count by 0% last year.
FabGennix International's People
Name | Title | Email/Phone |
---|---|---|
1 | Production Manager | Reveal Email/Phone |
FabGennix International Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is FabGennix International?
FabGennix International Incorporated is a biotechnology company dedicated to providing high grade research antibodies and reagents/kits to the biomedical scientific community. We provide custom antibody development and characterization services, and also carry over 1000 catalog antibodies related to Neuroscience, Cell Biology, cancer research, signal transduction and obesity research. FabGennix International Inc. is a single-source supplier of high quality protein research tools for life sciences. FabGennix also supports custom research, PDE inhibitor screening, protein purification and characterization and other molecular biology related projects. For a complete description and to learn more about FabGennix, visit our website, www.fabgennix.com.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 12 | -20% | N/A |
#2 | $1M | 12 | -48% | N/A |
#3 | $1M | 12 | 9% | N/A |
#4 | $1M | 12 | -25% | N/A |
#5 | $2.1M | 12 | 0% | N/A |